The final set of Molecules of the Month for 2023 is out, and now it’s time to nominate your favorite molecules for 2023’s Molecules of the Year! Nominees should have either been first disclosed in 2023 or had a major new update in 2023 (e.g. clinical trial readout, publication, business transaction, approval). The molecule must have a [...]

With initial signs of efficacy and tolerability, Drug Hunter has launched Phase III! To address your helpful feedback, we’ve rebuilt the platform from scratch to support new features and enhancements. We appreciate your patience with the rollout!

The final set of Molecules of the Month for 2022 is out, and now it’s time to nominate your favorite molecules for 2022’s Molecules of the Year! Nominees should have either been first disclosed in 2022 or had a major new update in 2022 (e.g. clinical trial readout, publication, business transaction, approval). The molecule must have a [...]

In the early 90’s, Wayne (Haifeng) Tang and Ray Zhao formed a friendship in high school in China. They were both stellar students in chemistry, and each was one of the country’s fraction of a percent to ace the notoriously difficult college entrance exams to land in China’s best universities. Wayne moved to the University of Science and [...]

Our first South San Francisco Drug Hunter event was so much fun, we've decided to host in-person events all over the world. The next few events will be networking mixers, but stay tuned for scientific symposia and conferences! Sign up here to get invites to future in-person events around the world, including in Boston, Basel, San Diego [...]

Announcement: Appointment of Drug Hunter Advisory Board Member: Andrew Setikas Drug Hunter is pleased to introduce a new member of our Advisory Board, Andrew Setikas. As Chief Business Officer at California Life Sciences, Andrew Setikas has been at the forefront of record growth for the organization, and during his tenure spearheaded efforts [...]

Announcement: Appointment of Drug Hunter Advisory Board Member: Gary Yeung, CFA Drug Hunter is pleased to introduce a new member of our Advisory Board, Gary Yeung . Gary Yeung is a life science executive (President, COO, CFO, and CBO), board member, advisor, and investor with extensive strategy, finance, business development, and operations [...]

Announcement: Appointment of Drug Hunter Advisory Board Member: Wendy Young, Ph. D . Drug Hunter is pleased to introduce a new member of our Advisory Board , Dr. Wendy Young. Wendy Young, Ph.D. is a seasoned drug hunter and biotechnology, pharma and life science executive with more than 25 years of experience in the discovery and development [...]

We've just published the final set of Molecules of the Month for 2021, and now it's time to nominate your favorite molecules for 2021's Molecules of the Year! Nominees should have either been first disclosed in 2021 or had a major new update in 2021 (e.g. clinical trial readout, publication, business transaction, approval). The molecule must [...]

Dear Drug Hunter, It's gotten harder and harder to keep up with everything that's going on in the industry. From new company launches to drug approvals, endless publications to regulatory updates, the volume of information drug discovery leaders need to make good decisions seems endless. Our mission is to save you time by curating industry [...]

Recently our non-profit partner, California Life Sciences , completed nominations for the 2021 Pantheon Award for Scientific Advancement . We’re glad to see several drug hunters and drug discovery companies across the award categories, and we hope you’ll help get some industry drug hunters deserved recognition for their achievements by voting [...]